Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12R - Indexing scheme associated with subclasses , relating to micro-organisms › C12R 1 - Micro-organisms
Patents for C12R 1 - Micro-organisms (92,025)
05/2003
05/22/2003US20030096953 Protein mixture for use in the detection of microbiocides
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030096723 Low temperature activation; washing detergents, high washing power
05/22/2003US20030096399 Enzymatic nucleotide sequence pool for use as tool in analysis of gene expression
05/22/2003US20030096385 High production method of prenyl alcohol by microorganisms
05/22/2003US20030096380 Microorganisms and processes for producing L-glutamine
05/22/2003US20030096341 Generation of preferential enzymatic polypeptide in eukaryote; obtain vector, minsert clone, transfrom eukaryotic cell, expres vector, purify polypeptide
05/22/2003US20030096296 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors
05/22/2003US20030096029 Remedies for allergic diseases and process for producing the same
05/22/2003US20030095987 Recombinant parainfluenza virus expression system and vaccines
05/22/2003US20030095964 Process for producing humanized chimera antibody
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/21/2003EP1312920A1 Method of screening remedy for heart failure
05/21/2003EP1312371A1 Animal papilla disinfectants and method of improving microbial environment
05/21/2003EP1312259A1 Type iii allergic inflammation model animal
05/21/2003EP1311719A1 A method for treating proteinaceous fibres
05/21/2003EP1311685A2 Nucleotide sequences which code for the ccpa1 gene
05/21/2003EP0877752B1 Methods for screening for transdominant effector peptides and rna molecules
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0835322B1 Dehalogenation of polyamine, neutral curing wet strength resins
05/21/2003EP0817640B1 Use of epithelial adhesive lactobacilli
05/21/2003EP0720618B1 Process for the purification of basic fibroblast growth factor
05/21/2003EP0707650B1 Process for producing human relaxin
05/21/2003EP0573551B1 Serine-rich peptide linkers
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419416A Cultured protein hydrolysate
05/21/2003CN1109103C Artificial culture of jiuzhou caterpillar fungus and the application of its sporophore
05/21/2003CN1108789C Liposomes contg. particulate materials
05/20/2003US6566583 Schizochytrium PKS genes
05/20/2003US6566513 Nucleotide sequences coding polypeptide for use as viricide
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566123 Biomass containing Thraustochytriales microflora
05/20/2003US6566120 Contacting compactin with an agent derived from Actinomadura under conditions in which agent converts compactin to pravastatin; anticholesterol agent
05/20/2003US6566114 Mannanases
05/20/2003US6566107 Microorganism for use in the conversion of a hydantoin into a racemic compound for use in generation of ethanol
05/20/2003US6566106 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof
05/20/2003US6566105 Process for the production of D-α-amino acids
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565855 Polypeptides; genetic engineering
05/20/2003US6565852 Tumor antigen; vaccine; antitumor, anticarcinogenic agents
05/20/2003CA2223579C Novel recombinant temperature sensitive mutants of influenza
05/20/2003CA2123416C Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from an aspergillus endoxylanase ii gene
05/20/2003CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment
05/20/2003CA2091668C Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles
05/20/2003CA2075695C Monoclonal antibodies to sulfonated polymers
05/15/2003WO2003040689A2 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003WO2003040384A1 Recombinant antibodies for the detection and neutralization of anthrax toxin
05/15/2003WO2003040379A2 Modulating urea degradation in wine yeast
05/15/2003WO2003040372A2 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
05/15/2003WO2003040349A1 Mixture of propionibacterium jensenii and lactobacillus sp. with with antimicrobial activities for the use as natural preservation system
05/15/2003WO2003040310A2 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003WO2003040181A2 Genes from the corynebacterium glutamicum coding for regulatory proteins
05/15/2003WO2003040179A1 High level constitutive production of anthrax protective antigen
05/15/2003WO2003039342A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
05/15/2003WO2003027302A9 Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455
05/15/2003US20030092897 Antigen composition against mycoplasma
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092155 Modified phytases
05/15/2003US20030092129 Nervous system polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030092097 Enzymatic polypeptide for use in the treatment of taxtiles and fabric
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092018 Cloned DNA polymerases from thermotoga neapolitana
05/15/2003US20030092006 Classification of preferential nucleotide sequences; obtain nucleotide sequences, insert into vector, transform cells, generate clones, generate ribonucleic acid from clones, divide sequences, amplify and measure sequence concentration
05/15/2003US20030091979 Apparatus for use in the generation of muscle tissue
05/15/2003US20030091596 Antiallergens; enzymeric dissolving of cell wall
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091550 Novel strains of bacillus thuringiensis and pesticidal composition comprising them
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091535 Mutant virus with defective genome; genetic engineering
05/15/2003CA2736469A1 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003CA2465839A1 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
05/15/2003CA2465679A1 High level constitutive production of anthrax protective antigen
05/15/2003CA2464977A1 Modulating urea degradation in wine yeast
05/15/2003CA2464470A1 Novel epidermal growth factor protein and gene, and methods of use therefor
05/14/2003EP1310798A2 Cell tests and diagnostic index for Alzheimer's disease
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310560A1 Method of modifying microorganism-origin transglutaminase
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310166A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function
05/14/2003EP1309715A2 3-hydroxycarboxylic acid production and use in branched polymers
05/14/2003EP1309714A1 Stereoselective reduction of substituted oxo-butanes
05/14/2003EP1309699A2 Elongase genes and uses thereof
05/14/2003EP1309675A2 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
05/14/2003EP1246631B1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
05/14/2003EP1228078B1 Preparation of a macrocyclic lactone
05/14/2003EP1107787B1 Salmonella typhi vaccine compositions
05/14/2003EP0868559B1 Use of xyloglucan endotransglycosylase (xet)
05/14/2003EP0868427B1 Methods for identifying compounds that bind to a target
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0813541B1 Process for producing a protein
05/14/2003EP0793724B1 Oxidoreductase from filamentous fungi, dna coding therefor and cells transformed with said dna
05/14/2003EP0672141B1 Methods of preparing soluble, oligomeric proteins
05/14/2003EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine
05/14/2003CN1418256A Beta glucans from filamentous fungi
05/14/2003CN1418249A Novel subtilase enzymes having an improved wash performance on egg stains
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 921